(MD+DI) – The orthopedic company known for its customized knee implants now plans to sell a standard off-the-shelf knee in parallel to its higher-cost customized knee implants. […]
Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation iTotal® Identity PS Knee System. […]
Conformis today said its full-time employees that were furloughed in March will return to active employment as early as April 27. The employees’s return is due to a $4.7 million loan made available to the company under the Paycheck Protection Program offered by the U.S. SBA. […]
(MD+DI) – The custom orthopedics company said it was furloughing 80 employees because of sharp declines in elective procedures resulting from the coronavirus pandemic. The news comes as President Trump announced he was pushing to ‘reopen’ the economy by Easter. […]
Under the terms of the agreements, Conformis will receive $14M up-front and up to an additional $16M in milestone payments for selling, licensing, and developing part of its intellectual property portfolio to Stryker in order to design, manufacture, and commercialize PSI for use in Stryker’s knee implant offerings, including the market-leading Triathlon Total Knee System. […]
Today Conformis, Inc. announced the results from a recent study presented at the Knee Society Meeting, entitled “Customized Knee Implants Drive Cost Savings in a Medicare Population”. The abstract was presented by Mary O’Connor, MD, Director of the Center for Musculoskeletal Care at Yale School of Medicine and Yale New Haven Health. […]
Copyright © 2023 | MH Magazine WordPress Theme by MH Themes